Cargando…
Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania
Background: The aim of this study was to assess the association between androgen deprivation therapy (ADT) and the risk of inflammatory rheumatic diseases in men with prostate cancer. Methods: Patients with prostate cancer between 2012 and 2016 were identified from the Lithuanian Cancer Registry and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999943/ https://www.ncbi.nlm.nih.gov/pubmed/35407647 http://dx.doi.org/10.3390/jcm11072039 |
_version_ | 1784685311956090880 |
---|---|
author | Drevinskaite, Mingaile Dadoniene, Jolanta Miltiniene, Dalia Patasius, Ausvydas Smailyte, Giedre |
author_facet | Drevinskaite, Mingaile Dadoniene, Jolanta Miltiniene, Dalia Patasius, Ausvydas Smailyte, Giedre |
author_sort | Drevinskaite, Mingaile |
collection | PubMed |
description | Background: The aim of this study was to assess the association between androgen deprivation therapy (ADT) and the risk of inflammatory rheumatic diseases in men with prostate cancer. Methods: Patients with prostate cancer between 2012 and 2016 were identified from the Lithuanian Cancer Registry and the National Health Insurance Fund database, on the basis of rheumatic diseases diagnoses and information on prescriptions for androgen deprivation therapy. Cox proportional hazard models were used to estimate hazard ratios (HR) to compare the risks of rheumatic diseases caused by androgen deprivation therapy exposure in groups of prostate cancer patients. Results: A total of 12,505 prostate cancer patients were included in this study, out of whom 3070 were ADT users and 9390 were ADT non-users. We observed a higher risk of rheumatic diseases in the cohort of prostate cancer patients treated with ADT compared with ADT non-users (HR 1.55, 95% confidence interval (CI) 1.01–2.28). Detailed risk by cumulative use of ADT was performed for rheumatoid arthritis, and a statistically significant higher risk was found in the group with longest cumulative ADT exposure (>105 weeks) (HR 3.18, 95% CI 1.39–7.29). Conclusions: Our study suggests that ADT usage could be associated with increased risk of rheumatoid arthritis, adding to the many known side effects of ADT. |
format | Online Article Text |
id | pubmed-8999943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89999432022-04-12 Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania Drevinskaite, Mingaile Dadoniene, Jolanta Miltiniene, Dalia Patasius, Ausvydas Smailyte, Giedre J Clin Med Article Background: The aim of this study was to assess the association between androgen deprivation therapy (ADT) and the risk of inflammatory rheumatic diseases in men with prostate cancer. Methods: Patients with prostate cancer between 2012 and 2016 were identified from the Lithuanian Cancer Registry and the National Health Insurance Fund database, on the basis of rheumatic diseases diagnoses and information on prescriptions for androgen deprivation therapy. Cox proportional hazard models were used to estimate hazard ratios (HR) to compare the risks of rheumatic diseases caused by androgen deprivation therapy exposure in groups of prostate cancer patients. Results: A total of 12,505 prostate cancer patients were included in this study, out of whom 3070 were ADT users and 9390 were ADT non-users. We observed a higher risk of rheumatic diseases in the cohort of prostate cancer patients treated with ADT compared with ADT non-users (HR 1.55, 95% confidence interval (CI) 1.01–2.28). Detailed risk by cumulative use of ADT was performed for rheumatoid arthritis, and a statistically significant higher risk was found in the group with longest cumulative ADT exposure (>105 weeks) (HR 3.18, 95% CI 1.39–7.29). Conclusions: Our study suggests that ADT usage could be associated with increased risk of rheumatoid arthritis, adding to the many known side effects of ADT. MDPI 2022-04-05 /pmc/articles/PMC8999943/ /pubmed/35407647 http://dx.doi.org/10.3390/jcm11072039 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Drevinskaite, Mingaile Dadoniene, Jolanta Miltiniene, Dalia Patasius, Ausvydas Smailyte, Giedre Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title | Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title_full | Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title_fullStr | Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title_full_unstemmed | Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title_short | Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania |
title_sort | association between androgen deprivation therapy and the risk of inflammatory rheumatic diseases in men with prostate cancer: nationwide cohort study in lithuania |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999943/ https://www.ncbi.nlm.nih.gov/pubmed/35407647 http://dx.doi.org/10.3390/jcm11072039 |
work_keys_str_mv | AT drevinskaitemingaile associationbetweenandrogendeprivationtherapyandtheriskofinflammatoryrheumaticdiseasesinmenwithprostatecancernationwidecohortstudyinlithuania AT dadonienejolanta associationbetweenandrogendeprivationtherapyandtheriskofinflammatoryrheumaticdiseasesinmenwithprostatecancernationwidecohortstudyinlithuania AT miltinienedalia associationbetweenandrogendeprivationtherapyandtheriskofinflammatoryrheumaticdiseasesinmenwithprostatecancernationwidecohortstudyinlithuania AT patasiusausvydas associationbetweenandrogendeprivationtherapyandtheriskofinflammatoryrheumaticdiseasesinmenwithprostatecancernationwidecohortstudyinlithuania AT smailytegiedre associationbetweenandrogendeprivationtherapyandtheriskofinflammatoryrheumaticdiseasesinmenwithprostatecancernationwidecohortstudyinlithuania |